Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Premier Graphene Inc BIEI

Healthcare Biotechnology
Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Company’s graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.


OTCPK:BIEI - Post by User

Premier Graphene Inc
Bullboard Posts
User Avatar Image
(58)
•••
Post by badgirl007on Aug 09, 2018 4:17pm
60 Views
Post# 28436014

Anti-Aging Patent - investors search initiated!

Anti-Aging Patent - investors search initiated!Since our announcement of filing of a patent application on an Anti-Aging technology, two separate and distinct agents have come forward and signed agreements with us to pursue potential domestic and foreign investors to finance the development and commercialization of this technology.

https://www.premierbiomedical.com/premier-biomedical-ceo-update-letter-july-2018/


https://www.stockhouse.com/companies/bullboard?symbol=biei&postid=27545256

https://www.premierbiomedical.com/


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities